Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neurogene (NGNE) Gross Margin: 2019-2025

Historic Gross Margin for Neurogene (NGNE) over the last 3 years, with Sep 2025 value amounting to 100.00%.

  • Neurogene's Gross Margin changed negligibly% to 100.00% in Q3 2025 from the same period last year, while for Sep 2025 it was 100.00%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of 100.00% for FY2024, which is negligibly% changed negligibly from last year.
  • Per Neurogene's latest filing, its Gross Margin stood at 100.00% for Q3 2025, which was down 0.00% from 100.00% recorded in Q2 2025.
  • In the past 5 years, Neurogene's Gross Margin ranged from a high of 100.00% in Q1 2023 and a low of 100.00% during Q1 2023.
  • Moreover, its 3-year median value for Gross Margin was 100.00% (2025), whereas its average is 100.00%.